medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Número 616

<< Anterior Siguiente >>

Rev Med Cos Cen 2015; 72 (616)


Muestreo venoso adrenal en paciente con hiperaldosteronismo primario: Reporte de caso

Soto HE, Gutierrez JLA, Salazar SR

Idioma: Español
Referencias bibliográficas: 25
Paginas: 597-605
Archivo PDF: 188.19 Kb.


RESUMEN

El hiperaldosteronismo primario es la causa más frecuente de hipertensión arterial secundaria. Su manejo clínico ha ido evolucionando significativamente durante los últimos 50 años, gracias a técnicas de tamizaje y diagnósticas más sensibles y específicas. El muestreo venoso adrenal para la diferenciación de hiperplasia adrenal bilateral del aldosteronoma o de la hiperplasia adrenal unilateral, es de suma importancia ya que el tratamiento difiere y se ha convertido en el método de elección debido a que la tomografía computarizada apenas consigue una sensibilidad del 50% para diferenciar entre estas enfermedades. En el presente caso se reporta el uso de este procedimiento en un paciente de 36 años con aldosteronoma izquierdo y dimensiones no bien detalladas por imagen radiológica.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Aronova A, Iii TJ, Zarnegar R. Management of hypertension in primary aldosteronism. World J Cardiol. 2014 May 26; 6(5): 227-33

  2. Conn JW. Presidential address: 1) Painting background. 2) Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 1955; 45:3-17

  3. Daunt N. Adrenal venous sampling hw to make it quick, easy and successful. Radiographics. 2005; 25(1): 143-158

  4. Doppman JL, Gill Jr JR. Hyperaldosteronism: sampling the adrenal veins. Radiology. 1996; 198: 309-312

  5. Funder et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: An endocrine society clinical practice guideline. J Clin Endocronol Metab. 2008; 93(9): 3266-3281

  6. Gordon RD. Diagnostic investigations in primary aldosteronismo. Clinical medicine series on hypertension, Mc Graw- Hill International. 2001; 101-111.

  7. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WI, Krek AI. Clinical and pathological diversity of primary aldosteronism, including new famiial variety. Clin Exp Pharmacol Physiol. 1991; 18:283- 286

  8. Iwaoka T, Umeda T, Sato T, Katsuragi S, Takeuchi T. High Plasma Renin Activity in Primary Aldosteronism with Malignant Hypertension. Jap Heart J 1980: 21(3): 423-28.

  9. Jiang Y, Zhang C, Wang W, Su T, Zhou W, Jing L et al. Diagnstic valu of ACTH stimulation test in determining the subtypes of primary aldosteronism. J Clin Endocrinol Metab. 2005 Feb 19: jc20143551

  10. Jonsson JM, Klemm SA, Tunny TJ, Stowasser M, Gordon RD. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension. Biochem Biophys Res Comm. 1995; 207: 565- 571

  11. Lim PO, Young WF, McDonald T. A review of the medical treatment of primary aldosteronism. J Hypertens 2001;19:353-361

  12. Litchfield WR, Anderson BF, Weiss Rj, Lifton RP, Dluby RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension. 1998; 32: 445-450

  13. Meyer A, Brabant G, Behrend M. Long term follow-up after adrenalectomy for primary aldosteronism. World J Surg. 2005; 29: 155-159.

  14. Oka K, Hayashi K, Nakazato T, Suzawa T, Fujiwara K, Saruta T. Malignant Hypertension in a patient with primary aldosteronism with elevated active renin concentration. Internal Medicine. 1997; 36: 700- 704.

  15. Piaditis G, Markou A, Papanastasiou L, Androulakis I, Kaltsas G. Progress in primary aldosteronism: A review of the prevalence of primary aldosteronism in pre-hypertension and hypertension. Eur J Endocrinol. 2014 Dec 23.

  16. Raman SP, Lessne M, Kawamoto S, Chen Y, Salvatori R, Prescott JD, et al. iagnostic performance of multidetector computed tomography in distinguishing unilateral from bilateral abnormalities in primary hyperaldosteronism: comparison of multidetector computed tomography with adrenal vein sampling. J Comput Assis Tomogr. 2015 Jan 15.

  17. Rossi GP, Aucus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014; 63:151-160

  18. Sawka AM, Young WF, Thompson Gb, Grant CS, Fairley DR, Leibson C, et al. Primary aldosteronism: Factors involved with normalization of blood pressure after surgery. Ann Intern Med. 2001; 135: 258-261

  19. Tanabe , Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab. 2003; 88: 2489- 2494

  20. Tiu SC, Choi CH, Shek CC, Ng YW, Chan FK, Ng CM, et al. The Use of Aldosterone-Renin Ratio as a Diagnostic Test for Primary Hyperaldosteronism and Its Test Characteristics under Different Conditions of Blood Sampling. The Journal of Clinical Endocrinology & Metabolism 2005; 90:72–78

  21. Trerotola SO, Asmar M, Yan Y, Fraker DL, Cohen DL. Failure mode analysis in adrenal vein sampling: a single-center experience. J Vasc Interv Radiol. 2014; 25(10):1611-9.

  22. Villarroel-Ábrego H, Rivas M, Sotello D, Sorto D. Hipertensión arterial maligna e hiperaldosteronismo hiperreninémico: reporte de un caso. Rev costarric. Cardiol. 2011;13(1): 29-34

  23. Weinberger MH, Grimm CF, Hollifield JW, Kern DC, Ganguly A, Kramer NJ, et al. Primary aldosteonism: Diagnosis, localization and treatment. Ann Intern Med. 1979; 90: 386-395

  24. Wolley MJ, Gordon RD, Ahmed A, Stowasser M. Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study. J Endocrinol Metab. 2015 Jan 30: jc20143676

  25. Young WF, Stanson AW, Thompson GB, Grant CS, Fairley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004; 136: 1227-1235.




2020     |     www.medigraphic.com